The speaker for the OHE’s 17th Annual Lecture was Dr Alan Garber, Director both of Stanford University’s Center for Health Policy and its Center for Primary Care and Outcomes Research at the School of Medicine. His remarks focused on the national health care legislation enacted in March 2010 in the US from a unique perspective – as a practicing professor of medicine, one of the world’s leading health economists, and an expert in health care policy. His overview touched on several of the key issues raised by the new law that relate to coverage, cost, and quality.
In 2009, the English NHS began collecting patient-reported outcome measures (PROMs) for four elective procedures. Using a series of structured questions that ask patients about their health from their point of view, PROMs are intended to enable the patient perspective to inform decision-making at all levels of the NHS.
The annual OHE Compendium of Health Statistics is the one-stop statistical information source on population and health trends in the UK, and the changing finances and structure of the NHS. Compiled independently by the OHE, it draws together data from a variety of scattered sources. The disparate data, some spanning more than 50 years, are consolidated into nearly 300 tables and graphs designed to be user-friendly. Full commentary and explanatory notes are provided.
Perhaps best known for his work in cost-benefit analysis, Alan Williams was a man of principle who developed guiding values in health care economics that embraced and encouraged active intellectual engagement and progression. He was concerned with the philosophical and ethical issues that underpin decision making and his courageous intellectual battles bore new ideas and revised ideology.
This compilation of papers and further discussions arising from OHE's Alan Williams tribute conference provides an analysis of the evolution and current status of key concepts in the field.
OHE’s 14th Annual Lecture was delivered by Professor Daniel Kahneman, winner of the 2002 Nobel Prize in Economic Sciences for his pioneering work integrating insights from psychological research into economic science, especially concerning human judgment and decision-making under uncertainty. His focus in the lecture was on whether and how the utility of health states can be measured and whether QALYs are adequate. He suggests that there are reasonable grounds for measuring both decision utility and experience utility, using measures that are duration-weighted and others that ar
About one pound of every eleven spent in the UK goes to health care, most to NHS care. A large body of data is available on health care inputs and expenditures; far less is known about the outcomes that the resources and activities produce. Yet, knowing the outcomes achieved by health services is essential to being able to achieve the greatest benefit, the best patient care, from the resources used. The effectiveness, efficiency and accountability of the NHS all depend on knowing the outcomes it is achieving.
For the purposes of defining the economic and policy issues facing the vaccine industry, the comments made here are based largely on the experience in the US, but with some discussion of the global vaccines environment.
Almost every paper in the literature on vaccines starts off with the observation that vaccines are among the most cost-effective of medical interventions, and yet the unfortunate situation (although perhaps not surprising to an economist) is that supply is precarious.